Reduced Duration and Severity of Illness: Regular use of the Tri-Immune Boost Injection may contribute to a decreased duration and severity of common illnesses, providing a proactive approach to health maintenance
Dissolve gently: Swirl in slow circles do not shake
For maintenance doses (1.0 to 2.4 mg) Higher concentrations (2.5 to 5 mg/mL) work better for maintenance doses because the draw volumes stay within syringe capacity
Sterile water (WFI) contains no preservative, so once a vial is opened, contamination occurs more quickly
Mice were given spatial memory and learning navigation tasks and were monitored for neuroinflammation and axonal damage
Heres what you need to know: Target Tissue: Works specifically on adipose tissue without systemic growth hormone effects or muscle tissue impact Mechanism: Activates beta-3 adrenergic receptors on fat cell membranes, triggering intracellular fat-burning cascades Primary Action: Stimulates hormone-sensitive lipase to break down stored triglycerides into free fatty acids for energy utilization Secondary Action: Inhibits lipogenic enzymes that convert excess calories into stored fat Regional Selectivity: Particularly effective on visceral (deep abdominal) and subcutaneous fat deposits with high beta-3 receptor concentration Preservation Effect: Targets fat tissue selectively without promoting muscle protein breakdown or affecting lean tissue Unique Advantage: Does not bind to growth hormone receptors, avoiding effects on IGF-1, glucose metabolism, or insulin sensitivity Research Validation: Clinical trials with 900+ participants confirmed selective fat metabolism effects with excellent safety profile The following guide provides detailed analysis of how AOD-9604 targets fat cells, from receptor binding to metabolic outcomes
